Land use changes by human activities have been the main causes of habitats and wildlife population degradation. In the Tehuantepec Isthmus in Oaxaca, the tropical habitat of the porcupine Sphiggurus mexicanus has been subject to vegetation and land use changes, causing its reduction and fragmentation. In this study, we estimated vegetation cover and land use (δn) change rates and assessed habitat availability and potential cor- ridors for possible porcupine movements to avoid its isolation. In the study area, the type of vegetation with the most change rate value was the savanna (δn = -2.9), transformed into induced grasslands. Additionally, we have observed the porcupine (since 2011) in semi-deciduous (δn = -0.87) and tropical dry (δn = -0.89) forests that have been transformed in temporal agriculture and mesquite and induced grasslands. The vegetation inhabited by the porcupine resulted in recording a total of 64 plant species (44 trees, nine vines, seven herbs, four shrubs), of which the vine Bunchosia lanceolata showed the highest importance value (41.85) followed by the trees Guazuma ulmifolia (22.71), Dalbergia glabra (18.05), and Enterolobium cyclocarpum (17.02). The habitat evaluation and potential corridor analysis showed that only 1 501.93ha could be considered as suitable habitats with optimum structural conditions (coverage, surface, and distances to transformed areas) to maintain viable populations of S. mexicanus, and 293.6 ha as corridors. An increasing destruction of the porcupines' habitat has been observed in the study area due to excessive logging, and actions for this species and its habitat conserva- tion and management have to be taken urgently.

Download full-text PDF

Source
http://dx.doi.org/10.15517/rbt.v62i4.13587DOI Listing

Publication Analysis

Top Keywords

change rates
8
porcupine sphiggurus
8
sphiggurus mexicanus
8
land changes
8
study area
8
induced grasslands
8
habitat
6
porcupine
5
consequences change
4
rates habitat
4

Similar Publications

The collective experience of moral distress: a qualitative analysis of perspectives of frontline health workers during COVID-19.

Philos Ethics Humanit Med

January 2025

Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, The Alfred Hospital, Monash University, Melbourne, Australia.

Background: Moral distress is reported to be a critical force contributing to intensifying rates of anxiety, depression and burnout experienced by healthcare workers. In this paper, we examine the moral dilemmas and ensuing distress personally and collectively experienced by healthcare workers while caring for patients during the pandemic.

Methods: Data are drawn from free-text responses from a cross-sectional national online survey of Australian healthcare workers about the patient care challenges they faced.

View Article and Find Full Text PDF

Assessment of bacterial positivity rate changes in anesthesia machine internal circuits within recovery rooms and associated risk factors.

BMC Anesthesiol

January 2025

Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, No.300 of Guangzhou Road, Gulou District, Nanjing, Jiangsu, 210029, China.

Objective: The objective of this study is to investigate bacterial proliferation within the internal circuits of anesthesia machines in post-anesthesia care units (PACUs) following the implementation of the new protocol, where 'a single dedicated external circuit is used for each individual patient.' This measure was introduced during the COVID-19 pandemic, in alignment with a novel prevention and control strategy.

Methods: Using the observational technique, we analyzed anesthesia machines in PACUs between July and September 2022.

View Article and Find Full Text PDF

Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON.

Lung

January 2025

National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, UMR 754, ERN-LUNG, Lyon, France.

Purpose: In the INBUILD trial in patients with progressive pulmonary fibrosis (PPF), nintedanib slowed the decline in forced vital capacity (FVC) versus placebo, with a safety profile characterised mainly by gastrointestinal events. INBUILD-ON, the open-label extension of INBUILD, assessed the safety of nintedanib during longer-term treatment. Data on FVC were collected.

View Article and Find Full Text PDF

Trends in the epidemiology of intravascular device-associated bacteremia among French hematology patients: insights from the SPIADI prospective multicenter study, 2020-2024.

Ann Hematol

January 2025

Mission Nationale Surveillance et Prévention des Infections Associées aux Dispositifs Invasifs (SPIADI), Centre d'Appui pour la Prévention des Infections Associées aux Soins en région Centre val de Loire, Centre Hospitalier Régional Universitaire, Hôpital Bretonneau, Tours, France.

Hematology patients require central venous catheters for cancer treatment and nutrition, which increases their risk of intravascular device-associated bacteremia. In the absence of recent data, we investigated intravascular device-associated bacteremia in this specific context. A three-month surveillance was conducted annually in 27 hematology wards, using a protocol derived from the HAI-Net ICU ECDC protocol (2020-2024).

View Article and Find Full Text PDF

Hypertensive disorders of pregnancy (HDP) are significant global health issues. This study utilized data from the Global Burden of Disease Study 2021 to analyze trends in incidence, prevalence, and Disability-Adjusted Life Years (DALY) associated with HDP across 204 countries from 1990 to 2021. The analysis employed estimated annual percentage changes and an age-period-cohort model, stratifying data by age, year, geographical region, and sociodemographic index (SDI).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!